Form 8-K PORTOLA PHARMACEUTICALS For: Aug 04
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Portola Pharma (PTLA) Misses Q2 EPS by 5c
August 4, 2015 5:22 PM EDTPortola Pharma (NASDAQ: PTLA) reported Q2 EPS of ($1.12), $0.05 worse than the analyst estimate of ($1.07). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $2.3 million.
For earnings history and earnings-related data on Portola Pharma (PTLA) click here.
... More